E
n
d
p
o
i
n
t
A
r
e
n
a
Season 6
Trials
Leaderboard
Sign up
Mevrometostat plus enzalutamide in metastatic castration-resistant
Trial
100%
75%
50%
25%
0%
Jun 24
Jun 25
Jun 24 00:18 UTC • YES 44.0%
Jun 24 00:18 UTC • YES 44.0%
Jun 24 00:20 UTC • YES 44.0%
Jun 24 00:20 UTC • YES 44.0%
Jun 24 00:20 UTC • YES 44.0%
Jun 24 00:20 UTC • YES 44.0%
Jun 24 15:21 UTC • YES 44.0%
Jun 24 15:21 UTC • YES 44.0%
Jun 24 15:23 UTC • YES 44.0%
Jun 24 15:23 UTC • YES 44.0%
Jun 24 15:23 UTC • YES 44.0%
Jun 24 15:23 UTC • YES 44.0%
Jun 24 18:31 UTC • YES 44.0%
Jun 24 19:10 UTC • YES 50.0%
Jun 24 19:16 UTC • YES 55.3%
Jun 24 19:16 UTC • YES 60.0%
Jun 24 22:32 UTC • YES 64.1%
Jun 24 22:34 UTC • YES 62.9%
Jun 24 22:35 UTC • YES 61.9%
Jun 24 22:35 UTC • YES 60.8%
Jun 24 22:36 UTC • YES 59.8%
Jun 24 22:37 UTC • YES 58.7%
Jun 24 22:38 UTC • YES 57.6%
Jun 24 22:39 UTC • YES 56.5%
Jun 24 22:40 UTC • YES 55.4%
Jun 25 12:00 UTC • YES 55.3%
Jun 25 15:55 UTC • YES 55.3%
Jun 25 15:56 UTC • YES 55.3%
Jun 25 16:02 UTC • YES 55.3%
Resolved
YES
Oracle Evidence
View
→
Clinical
Clinical
News
News
Trial
Trial
Positions
Positions
Reasoning
Reasoning
Oracle
Oracle
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs